| 2023 | Pharmacokinetic and pharmacodynamic drug-drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers | CTS-CLINICAL AND TRANSLATIONAL SCIENCE |
| 2023 | Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects | Translational and Clinical Pharmacology |
| 2021 | Pharmacokinetics and safety of evogliptin in hepatically impaired patients | British Journal of Clinical Pharmacology |
| 2020 | Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus Infection | Clinical Gastroenterology and Hepatology |
| 2020 | Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects | Translational and Clinical Pharmacology |
| 2019 | Comparison of the Pharmacokinetic-Pharmacodynamic Relationships of Two Darbepoetin Alfa Formulations in Healthy Male Volunteers
| BioDrugs |
| 2019 | The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult male
| Drug Design, Development and Therapy |
| 2018 | Comparison of biosimilar filgrastim with a reference product: Pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers | Drug Design, Development and Therapy |
| 2018 | Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans | KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY |
| 2017 | Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers | Translational and Clinical Pharmacology |
| 2017 | Use of a Target-Mediated Drug Disposition Model to Predict the Human Pharmacokinetics and Target Occupancy of GC1118, an Anti-epidermal Growth Factor Receptor Antibody | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY |
| 2017 | Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation
| SCIENTIFIC REPORTS |
| 2017 | Decreased potency of fimasartan in liver cirrhosis was quantified using mixed-effects analysis
| Translational and Clinical Pharmacology |
| 2016 | Comparison of oral absorption models for pregabalin: usefulness of transit compartment model
| Drug Des Devel Ther |
http://orcid.org/0000-0001-7490-0085
(54792915700)
